Gibiate
On Tokyo MX
A post-apocalyptic action anime that pairs samurai-era warriors with modern survival horror, sustained across 12 episodes by constant combat and environmental threat.
In 2030, Japan. A virus has infected humans throughout the world. Infected people turn into different forms of monsters based on their ages, sexes and races. The virus is named 'Gibia' - after being rich in variety like gibia. Just then, a pair of samurai and ninja appeared in such a blighted wasteland of Japan. They both traveled from the early Edo period, fighting together with help from a doctor who tries to find cure for Gibia. Facing ceaseless attacks from Gibias, and outlaws that attack travelers for food, they start the dangerous journey with enemies all around.
Where to watch
- StreamCrunchyroll
Questions people ask
Is Gibiate violent? Yes, very. More violent than 92% of series.
Is Gibiate scary? Yes. More frightening than 89% of series.
Is Gibiate easy watching? Barely. Less comforting than 75% of series.
Does Gibiate leave you hopeful? Not especially. Less hopeful than 73% of series.
Is Gibiate sad? Somewhat. More sad than 66% of series.
These describe how the series comes across across its whole run, compared with other well-known series. They are not a content list — nothing here was counted or checked episode by episode, so for age-suitability or specific content use a classification board or a dedicated content-warning service.
Cinnamon Score
How much this series gives you that nothing else will, and whether it delivers.
Familiar shape, done well.
How unlike any other series this one feels
How much more it delivers than it promises
How much audiences actually like it
Ensemble
Like Gibiate
Nearest across the full emotional profile.
Same Mood as Gibiate
Nearest on what's most distinctive about this one.
Like Gibiate, But Darker
Similar, pushed toward heavier and more intense.
Like Gibiate, But Lighter
Similar, pushed toward warmer and easier.
Like Gibiate, But Less Popular
Same territory, far fewer people have seen it.
